Apr 05, 2022 8:30am EDT Stevanato Group Files Amendment No.1 to Its 2021 Annual Report on Form 20‑F/A
Mar 17, 2022 4:30pm EDT Stevanato Group to Present at KeyBanc Capital Markets Life Sciences & MedTech Investor Forum
Mar 01, 2022 8:30am EST Stevanato Group Announces Agreement With BARDA for the Expansion of Vial Production to Create Industrial Base Capabilities for National Defense
Jan 26, 2022 8:00am EST Stevanato Group Extends Pen Injector Technology Licensing Agreement With Haselmeier
Nov 09, 2021 6:30am EST Stevanato Group Reports Strong Third Quarter 2021 Revenue and Financial Results and Updates Full Year 2021 Guidance